DelveInsight’s “Pediatric Obesity Market Insights, Epidemiology, and Market Forecast-2032“ report delivers an in-depth understanding of the Pediatric Obesity, epidemiology insights, Pediatric Obesity market trends, therapies, and key companies working in the Pediatric Obesity Market in the 7MM.
Pediatric Obesity Overview
Overweight and obesity are defined as abnormal or excessive fat accumulation that presents a risk to health. A body mass index (BMI) over 25 is considered overweight, and over 30 is obese. Many genetic, physiologic, environmental, and socioeconomic factors influence the development of childhood obesity.
Pediatric Obesity Epidemiology Insights
The prevalence of obesity among children aged 6 to 11 increased significantly from 4.2% to 15.3%.
The prevalence of obesity in the United States for children and teens is 18.5%. The rate is even higher for adolescents, at 20.6% for 12 to 19-year-olds.
Approximately 13.5 million American adolescents struggle with obesity.
Click here to learn more about the Pediatric Obesity Market Landscape
The Report Covers the Pediatric Obesity Epidemiology Segmented by:
Total Pediatric Obesity incident cases
Total Pediatric Obesity prevalent cases
Total Pediatric Obesity treatment cases
Total Pediatric Obesity diagnostic cases
Pediatric Obesity Market Outlook
The Pediatric Obesity market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Pediatric Obesity market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand of better technology.
This segment gives a thorough detail of the Pediatric Obesity market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Pediatric Obesity market in 7MM is expected to change in the study period 2019-2032.
Key Companies Working in the Pediatric Obesity Market
United Health Group
Rhythm Pharmaceuticals
Novartis Pharmaceuticals
Eisai Pharmaceuticals
And many others
Pediatric Obesity Therapies Covered and Analyzed in the Report
VI-0521 mild dose
VI-0521 top dose
Setmelanotide
Metformin
And many others
Learn more about the Key Companies and Emerging Therapies in the Pediatric Obesity Market
Table of Contents
Key Insights
Pediatric Obesity Introduction
Executive Summary of Pediatric Obesity
Disease Background and Overview
Epidemiology and patient population
Pediatric Obesity Emerging Therapies
Pediatric Obesity Market Outlook
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @ Pediatric Obesity Market Outlook
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services